Cadence Pharmaceuticals, (FRA:QEW) EV-to-FCF : -48.99 (As of Jun. 22, 2024)

Cadence Pharmaceuticals, EV-to-FCF Chart

Cadence Pharmaceuticals, Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
EV-to-FCF		Get a 7-Day Free Trial					-9.06	-4.49	-	-	-34.11

Cadence Pharmaceuticals, Quarterly Data
	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cadence Pharmaceuticals,'s EV-to-FCF

For the Biotechnology subindustry, Cadence Pharmaceuticals,'s EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cadence Pharmaceuticals,'s EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cadence Pharmaceuticals,'s EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Cadence Pharmaceuticals,'s EV-to-FCF falls into.

Cadence Pharmaceuticals, EV-to-FCF Calculation

Cadence Pharmaceuticals,'s EV-to-FCF for today is calculated as:

Cadence Pharmaceuticals,'s current Enterprise Value is €887.38 Mil.
Cadence Pharmaceuticals,'s Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €-18.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cadence Pharmaceuticals,  (FRA:QEW) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cadence Pharmaceuticals,'s PE Ratio for today is calculated as:

Cadence Pharmaceuticals,'s share price for today is €9.95.
Cadence Pharmaceuticals,'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.216.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Cadence Pharmaceuticals, EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Cadence Pharmaceuticals,'s EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Cadence Pharmaceuticals, (FRA:QEW) Business Description